reported bloomberg pharmalot furious seasons fda official overruled fda reviewers put zyprexa track approval treating adolescent schizophrenia bipolar disorder lilly claims plans major marketing campaign yet given glut atypical antipsychotics frequent use among kids already concerns associated zyprexa side effects lilly market aggressively order win scripts bloomberg also reported abilify seroquel may win fda approval youth market long risperdal going generic soon lilly either market drug like hell i operation restore confidence part two accept minor piece market perhaps care maybe studies attempt generate good publicity extend patent six months estimated worth billion dollars